| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $17K | +1696.3% |
| R&D Expense | $145K | +258.9% |
| SG&A Expense | $6.9M | +57.6% |
| Operating Income | -$7.2M | -59.2% |
| Interest Expense | $6.7M | — |
| Pre-tax Income | -$8.4M | -79.7% |
| Net Income | -$8.4M | -79.7% |
| EPS (Basic) | -$0.66 | +56.3% |
| EPS (Diluted) | -$0.66 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $0 | — |
| Accounts Receivable | $5K | — |
| Current Assets | $2.8M | -53.0% |
| Total Assets | $4.5M | -28.6% |
| Current Liabilities | $841K | -56.8% |
| Total Liabilities | $1.5M | -22.8% |
| Stockholders' Equity | $3.0M | -31.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.7M | -11.4% |
| Capital Expenditures | $576K | — |
| Investing Cash Flow | -$794K | -115.8% |
| Financing Cash Flow | $3.6M | -59.9% |
| Free Cash Flow | -$6.2M | — |
| +56.3% |